What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
Diomidis BotsikasIlias BagetakosMarlise PicarraAna Carolina Da Cunha Afonso BarisitsSana BoudabbousXavier MontetGiang Thanh LamIsmini MaintaAnastasia KalovidouriMinerva BeckerPublished in: European radiology (2018)
• N and M breast cancer staging performance of PET/MR and PET/CT is similar per patient. • In a lesion-per-lesion analysis PET/MR is more sensitive than PET/CT especially for bone metastasis. • Readers' diagnostic confidence is similar for both tests.